Cargando…

Isoniazid-induced liver disorder in the treatment of tuberculosis

Detalles Bibliográficos
Autores principales:	Sivannan, Srinivasan, Vishnuvardhan, Atukuri, Elumalai, Karthikeyan, Srinivasan, Sivaneswari, Eluri, Kalpana, Elumalai, Manogaran, Muthu, Ramasamy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chinese Medical Association 2018
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308916/ https://www.ncbi.nlm.nih.gov/pubmed/30603745 http://dx.doi.org/10.1016/j.cdtm.2018.11.003

Ejemplares similares

Clinical condition and medication therapy of amoxicillin‐induced Stevens‐Johnson syndrome: A case report
por: Srinivasan, Sivannan, et al.
Publicado: (2019)

Acetylcholinesterase enzyme inhibitor activity of some novel pyrazinamide condensed 1,2,3,4-tetrahydropyrimidines
por: Elumalai, Karthikeyan, et al.
Publicado: (2014)

Development of acrocyanosis associated with pain and increased creatinine level in histoplasmosis patient: Medication therapy
por: Yadhav, Chittiboyena Sai Chaitanya, et al.
Publicado: (2018)

Aged diabetic amputee with COVID-19: A medication therapy
por: Salkapuram, Sunil Kumar, et al.
Publicado: (2022)

Aged diabetic amputee with COVID‐19: A medication therapy
por: Salkapuram, Sunil Kumar, et al.
Publicado: (2022)

(Z)-3-(2-Aminoanilino)-1-phenylbut-2-en-1-one
por: Karthikeyan, Subramani, et al.
Publicado: (2013)

‘Recognized journals’ in guidelines from Central Council of Indian Medicine on research publications needs specification
por: Muthappan, Sendhilkumar, et al.
Publicado: (2018)

A Lower Dose of Efavirenz Can Be Coadministered With Rifampicin and Isoniazid in Tuberculosis Patients
por: Kaboggoza, Julian P, et al.
Publicado: (2019)

Isoniazid and Pulmonary Fibrosis
por: Chung, Chae Uk, et al.
Publicado: (2015)

A novel COVID-19 and its effects on cardiovascular disease
por: Paramasivam, Arumugam, et al.
Publicado: (2020)

Reliability of Mycobacterial Growth Indicator Tube (MGIT) 960 for the detection of isoniazid resistance in a tuberculosis endemic setting
por: Gomathi, N.S., et al.
Publicado: (2014)

Bayesian spatio-temporal model for tuberculosis in India
por: Srinivasan, R., et al.
Publicado: (2015)

Treatment of isoniazid-resistant pulmonary tuberculosis
por: Kim, Yee Hyung, et al.
Publicado: (2008)

Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
por: Jhun, Byung Woo, et al.
Publicado: (2020)

Review of adverse events associated with COVID-19 vaccines, highlighting their frequencies and reported cases
por: Yaamika, Harshini, et al.
Publicado: (2023)

Ethyl 2-(4-chlorophenyl)-1-phenyl-1H-benzimidazole-5-carboxylate
por: Yoon, Yeong Keng, et al.
Publicado: (2012)

Ethyl 4-anilino-3-nitrobenzoate
por: Yoon, Yeong Keng, et al.
Publicado: (2012)

Dose of Isoniazid in Renal Disease for Treatment of Tuberculosis
por: Sarma, G. R. K.
Publicado: (2022)

Need to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible cases
por: Vadwai, Viral, et al.
Publicado: (2012)

4′-(4-Fluorophenyl)-1′-methyldispiro[indane-2,2′-pyrrolidine-3′,2′′-indane]-1,3,1′′-trione methanol hemisolvate
por: Ali, Mohamed Ashraf, et al.
Publicado: (2013)

Electrospun Orodispersible Films of Isoniazid for Pediatric Tuberculosis Treatment
por: Chachlioutaki, Konstantina, et al.
Publicado: (2020)

Impact of Isoniazid Resistance-Conferring Mutations on the Clinical Presentation of Isoniazid Monoresistant Tuberculosis
por: Dantes, Raymund, et al.
Publicado: (2012)

Isoniazid Prophylaxis for Latent Tuberculosis Infections in Liver Transplant Recipients in a Tuberculosis-Endemic Area
por: Moon, Hyung Hwan, et al.
Publicado: (2017)

Isoniazid-Induced Acute Liver Failure Requiring Liver Transplantation
por: Almeida, Mariana S, et al.
Publicado: (2022)

Comment on: “A structured pathway for accelerated postoperative recovery reduces hospital stay and cost of care following microvascular breast reconstruction without increased complications”
por: Chin, Ye Ru, et al.
Publicado: (2021)

Isoniazid-Induced Acute Psychosis in a Patient with Pleural Tuberculosis
por: Gomes, Joana, et al.
Publicado: (2019)

F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Muscle Uptake in Antiglutamic Acid Decarboxylase Antibody-positive Stiff-person Syndrome
por: Kamaleshwaran, Koramadai Karuppusamy, et al.
Publicado: (2023)

Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014
por: Cornejo Garcia, Jose Gabriel, et al.
Publicado: (2018)

Cytocompatibility and Wound Healing Activity of Chitosan Thiocolchicoside Lauric Acid Nanogel in Human Gingival Fibroblast Cells
por: M, Ameena, et al.
Publicado: (2023)

Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia
por: Getahun, Muluwork, et al.
Publicado: (2022)

Isoniazid-Resistant Tuberculosis, Taiwan, 2000–2010
por: Lai, Chih-Cheng, et al.
Publicado: (2011)

Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis
por: Balcells, Maria Elvira, et al.
Publicado: (2006)

Isoniazid for preventing tuberculosis in HIV‐infected children
por: Zunza, Moleen, et al.
Publicado: (2017)

Morvan Syndrome Manifesting as Autoimmune Paraneoplastic Encephalitis Associated with Thymoma and Antivoltage Gated Potassium Channel (Leucine Rich, Glioma Inactivated 1) Antibody Detected using F 18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
por: Kamaleshwaran, Koramadai Karuppusamy, et al.
Publicado: (2022)

Isoniazid-specific T-cell Responses in patients with anti-tuberculosis drug related liver injury
por: Usui, Toru, et al.
Publicado: (2014)

A Case of Acute Liver Failure in a Patient on Isoniazid Prophylaxis for Latent Tuberculosis
por: Philipose, Jobin, et al.
Publicado: (2022)

Retraction: Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques
Publicado: (2021)

Isoniazid-Induced Severe Hepatotoxicity: An Infrequent but Preventable Cause of Liver Failure in Children Treated for Latent Tuberculosis Infection
por: Desrochers, Dan, et al.
Publicado: (2011)

Isoniazid-induced alopecia
por: Gupta, K. B., et al.
Publicado: (2011)

Effect of rifampicin & isoniazid on the steady state pharmacokinetics of moxifloxacin
por: Ramachandran, Geetha, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_c1pebjth2k4svim33gen6koq0o